Understanding chronic lymphocytic leukemia in clinic patients
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study aims to learn more about chronic lymphocytic leukemia (CLL) and closely related conditions. It may help researchers better understand who gets CLL and how it behaves over time, which can improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with monoclonal B-cell lymphocytosis or chronic lymphocytic leukemia (CLL) or a similar low-grade blood disorder.
- You are a new or existing patient getting treatment for these conditions.
- You are being seen at the Dana-Farber Cancer Institute hematology/oncology clinic, or you received care elsewhere but have CLL.
- The study is focused on low-grade (slower-growing) lymph node/blood-related conditions rather than high-grade illnesses.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry collects information over time from people with CLL to better understand the disease and its treatment. It does not test any new drugs or procedures.
This is a study that looks back and forward at people diagnosed with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or a related early condition called MBL. It aims to improve how these conditions are recognized and managed over time in Italy.
This study looks at families where more than one person has a blood cell disorder (lymphoproliferative disorder) to understand why it runs in families. If you or a relative have this condition, you may help researchers learn more about it.
This trial studies how the body makes blood cells in people with chronic lymphocytic leukemia (CLL), a related condition called monoclonal B-cell lymphocytosis (MBL), and in healthy volunteers matched by age. The goal is to understand differences that may help improve treatment or monitoring.
This study measures how your body’s metabolism works in people with chronic lymphocytic leukemia (CLL). It uses blood tests, and for some people, a bone marrow sample, to better understand what’s happening and potentially guide future treatments.
This trial looks at how doctors and nurses decide when to refer patients with chronic lymphocytic leukemia (a slow-growing blood cancer) for specialist care. It aims to understand variations in referral practices and potentially improve the care pathway.
Hear when a new Chronic Lymphocytic Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.